• Explore /
  • Poster
  • / A pilot study of ipilimumab and nivolumab in recurrent extensive-stage small cell lung cancer after platinum-based chemotherapy.

A pilot study of ipilimumab and nivolumab in recurrent extensive-stage small cell lung cancer after platinum-based chemotherapy.

Abstract Poster

Authors

null

Anne C. Chiang

Yale Cancer Center, New Haven, CT

Anne C. Chiang , Matthew Austin , Tyler F. Stewart , Mohammad Arammash , Sunil Bhatt , Scott N. Gettinger , Sarah B. Goldberg , Frederick Hugh Wilson , Benjamin Robert Newton , Michael Keith Cohenuram , Kert D. Sabbath , Ashita D. Talsania , Armand Vincent Russo , Roy S. Herbst , Kurt A. Schalper

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Small Cell Lung Cancer

Clinical Trial Registration Number

03670056

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 8583)

DOI

10.1200/JCO.2022.40.16_suppl.8583

Abstract #

8583

Poster Bd #

209

Abstract Disclosures

Similar Posters

First Author: Edwin R. Parra

Poster

2020 ASCO Virtual Scientific Program

A phase II single-arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated classical Kaposi sarcoma (CKS).

A phase II single-arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated classical Kaposi sarcoma (CKS).

First Author: Alona Zer

First Author: Aparna Raj Parikh

First Author: Gerard Zalcman